Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Carnitine, National Institutes of Health (2023) Effects of three treatment modalities (diet, myoinositol, or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome, European Review for Medical and Pharmacological Sciences (2019) Who can perform semaglutide treatments?, American Med Spa Association (2023) Using fat-dissolving injections that are not FDA-approved can be harmful, U.S
Andrici, J., Tio, M., Cox, M
Zambo V, Simon-Szabo L, Szelenyi P, Kereszturi E, Banhegyi G, Csala M
An interim analysis was planned after two thirds of the total events had accrued with clear stopping rules and an alpha spending function to account for this interim look (in fact, the interim analysis did not take place until 741 events, out of the planned 854, took place)
If you are still not sure where to begin, our Cymbiotika Expert quiz can help you find a personalized starting point